Consistent with our findings, Chen et al. show that FAM83A expression is elevated in PDAC patients and high expression correlates with significantly poor overall and disease free survival, due in part to the gain of cancer stem cell features and chemoresistance to Gemcitabine38. The gene discussed is SACK1A; the disease is cancer.